EZCORP (NASDAQ:EZPW) Stock, Quote.Headers.trade-ideas

EZCORP

EZCORP Inc is a United States-based company engaged in offering pawn loans in the United States and Mexico. It also offers short-term unsecured loans and other consumer financial products, and buy and sell second-hand goods. The operating segments of the company are us Pawn, Latin America Pawn, and other international. us Pawn segment includes all pawn activities in the United States. Latin America Pawn segment includes all pawn activities in Mexico and other parts of Latin America. The company generates revenue from merchandise sales, jewelry scrapping sales, and pawn service charges, of which key revenue is derived from the merchandise sales which are primarily collateral forfeited from pawn lending operations and used merchandise purchased from the customers.

Earnings

News

Small Cap

Markets

Analyst Ratings

Trading Ideas

EZPW

While &#34;the trend is your friend&#34; when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure the sustainability of a trend isn&#39;t easy.

Recent Price Trend in Ezcorp is Your Friend, Here&#39;s Why

Latin America

Tech

CLMB

NWPX

TILE

WLDN

U.S. stock markets suffered a bloody blow in the first week of August. Wall Street&#39;s turmoil was triggered by weak labor market data, which heightened concerns of a near-term recession. The massive unwinding of Yen-carry trade due to an unexpected rate hike by the Bank of Japan aggravated the situation.

5 Stocks With Recent Price Strength in an Uncertain Market

wall-street-ai17

Intraday Update

Movers

BFAM

CERS

DASH

FTEL

GDDY

ICFI

MELI

TNDM

MercadoLibre Posts Upbeat Results, Joins Integral Ad Science, Willdan Group, Fresh Del Monte Produce And Other Big Stocks Moving Higher On Friday

EZCORP, Inc. - Class A Non-Voting Common Stock

EZCORP Inc

EZCORP To Acquire 53 Pawn Stores From Presta Dinero; Financial Terms Not Disclosed

While &quot;the trend is your friend&quot; when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure the sustainability of a trend isn&#39;t easy.
Often, the direction of a stock&#39;s price movement reverses quickly after taking a position in it, making investors incur a short-term capital loss. So, it&#39;s important to ensure that there are enough factors -- such as sound fundamentals, positive earnings estimate revisions, etc. -- that could keep the momentum in the stock going.
Investors looking to make a profit from stocks that are currently on the move may find our &quot;Recent Price Strength&quot; screen pretty useful. This predefined screen comes handy in spotting stocks that are on an uptrend backed by strength in their fundamentals, and trading in the upper portion of their 52-week high-low range, which is usually an indicator of bullishness.
There are several stocks that passed through the screen:
<h2>Ezcorp</h2>
(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ezpw#NASDAQ">EZPW</a>) is one of them. Here are the key reasons why this stock is a solid choice for &quot;trend&quot; investing.
A solid price increase over a period of 12 weeks reflects investors&#39; continued willingness to pay more for the potential upside in a stock. EZPW is quite a good fit in this regard, gaining 16.7% over this period.
However, it&#39;s not enough to look at the price change for around three months, as it doesn&#39;t reflect any trend reversal that might have happened in a shorter time frame. It&#39;s important for a potential winner to maintain the price trend. A price increase of 4.7% over the past four weeks ensures that the trend is still in place for the stock of this consumer financial services company.
Moreover, EZPW is currently trading at 92.1% of its 52-week High-Low Range, hinting that it can be on the verge of a breakout.
Looking at the fundamentals, the stock currently carries a Zacks Rank #2 (Buy), which means it is in the top 20% of more than the 4,000 stocks that we rank based on trends in earnings estimate revisions and EPS surprises -- the key factors that impact a stock&#39;s near-term price movements.
The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988.
Another factor that confirms the company&#39;s fundamental strength is its Average Broker Recommendation of #1 (Strong Buy). This indicates that the brokerage community is highly optimistic about the stock&#39;s near-term price performance.
So, the price trend in EZPW may not reverse anytime soon.
<a href="https://www.zacks.com/stock/news/2332608/recent-price-trend-in-ezcorp-ezpw-is-your-friend-here-s-why?cid=CS-BENZ-FT-tale_of_the_tape|recent_price_strength_screen-2332608">To read this article on Zacks.com click here.</a>

Recent Price Trend in Ezcorp is Your Friend, Here's Why

U.S. stock markets suffered a bloody blow in the first week of August. Wall Street&#39;s turmoil was triggered by weak labor market data, which heightened concerns of a near-term recession. The massive unwinding of Yen-carry trade due to an unexpected rate hike by the Bank of Japan aggravated the situation.
However, U.S. stock markets recovered their lost ground to a great extent within the next 3-4 trading sessions as more released data showed that the fundamentals of the U.S. economy remain firm. Market participants started to buy on the dip.
Consequently, a few stocks have shown price strength. We have primarily targeted stocks that have recently been on a bull run. Such stocks have a high chance of carrying the momentum forward.
If a stock is continuously witnessing an uptrend, there must be a solid reason or it would have probably crashed. So, looking at stocks capable of beating the benchmark that they have set for themselves seems rational.
However, recent price strength alone cannot create magic. Therefore, other relevant parameters are needed to create a successful investment strategy.
Here&#39;s how you should create the screen to shortlist the current as well as the potential winners.
<h2>Screening Parameters:</h2>
Percentage Change in Price (4 Weeks) greater than zero: This criterion shows that the stock has moved higher in the last four weeks.
Percentage Change Price (12 Weeks) greater than 10: This indicates that the stock has seen momentum over the last three months. This lowers the risk of choosing stocks that may have drawn attention due to the overwhelming performance of the overall market in a very short period.
Zacks Rank 1: No matter whether market conditions are good or bad, stocks with a Zacks Rank #1 (Strong Buy) have a proven history of outperformance.
Average Broker Rating 1: This indicates that brokers are also highly hopeful about the stock&#39;s future performance.
Current Price greater than 5: The stocks must all be trading at a minimum of $5.
Current Price/ 52-Week High-Low Range more than 85%: This criterion filters stocks that are trading near their respective 52-week highs. It indicates that these are strong enough in terms of price.
Just these few criteria narrowed down the search from over 7,700 stocks to seven.
Let&#39;s discuss five out of these seven stocks:
Climb Global Solutions Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clmb#NASDAQ">CLMB</a>) operates as a value-added information technology distribution and solutions company in the United States, Canada, Europe, the United Kingdom, and internationally. CLMB operates in two segments, Distribution and Solutions. CLMB markets its products through its own web sites, local and on-line seminars, events, webinars, and social media, as well as direct email and printed materials.
CLMB distributes technical software to corporate and value-added resellers, consultants, and systems integrators under the name Climb Channel Solutions, and provides cloud solutions and resells software, hardware, and services under the name Grey Matter.
The stock price of Climb Global Solutions has soared 55.2% in the past four weeks. The company has expected earnings growth of 7.4% for the current year. The Zacks Consensus Estimate for the current year has improved 0.001% over the last 60 days.
EZCORP Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ezpw#NASDAQ">EZPW</a>) is engaged in establishing, acquiring, and operating pawnshops that function as convenient sources of consumer credit and value-oriented specialty retailers of primarily previously owned merchandise. Through its lending function, EZPW makes relatively small, non-recourse loans secured by pledges of tangible personal property. EZPW contracts for a pawn service charge to compensate it for each pawn loan.
The stock price of EZCORP has climbed 15.3% in the past four weeks. It has an expected earnings growth rate of 22.8% for the current year (ending September 2024). The Zacks Consensus Estimate for current-year earnings has improved 0.2% over the last 30 days.
Willdan Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wldn#NASDAQ">WLDN</a>) is a provider of professional technical and consulting services to utilities, private industry and public agencies at all levels of government. WLDN enables its clients to realize cost and energy savings by providing a wide range of specialized services.&nbsp;
WLDN assists its clients with a broad range of complementary services relating to: Energy Efficiency and Sustainability, Engineering and Planning, Economic and Financial Consulting, and National Preparedness and Interoperability.
The stock price of Willdan Group has surged 12.1% in the past four weeks. It has an expected earnings growth rate of 12.6% for the current year. The Zacks Consensus Estimate for current-year earnings has improved 5.9% over the last 30 days.
Northwest Pipe Co. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nwpx#NASDAQ">NWPX</a>) manufactures welded steel pipe in two business segments. In Water Transmission business, NWPX is a supplier of large diameter, high-pressure steel pipe used primarily for water transmission. In Tubular Products business, NWPX manufacture smaller diameter, electric resistance welded steel pipe for use in a wide range of construction, agricultural, energy and industrial applications.
The stock price of Northwest Pipe has appreciated 10.4% in the past four weeks. It has an expected earnings growth rate of 41.6% for the current year. The Zacks Consensus Estimate for current-year earnings has improved 20.3% over the last 30 days.
Interface Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tile#NASDAQ">TILE</a>) designs, produces, and sells modular carpet products primarily worldwide. TILE operates in two segments, Americas, and Europe, Africa, Asia and Australia. TILE offers modular carpets under the Interface and FLOR brand names, luxury vinyl tiles, carpet tiles under the CQuestGB name for use in commercial interiors, include offices, healthcare facilities, airports, educational and other institutions, hospitality spaces, and retail facilities, as well as residential interiors; and modular resilient flooring products.&nbsp;
TILE also provides carpet replacement, installation, and maintenance services; and rubber flooring under the norament and noraplan brand names, as well as produces and sells an adapted version of its carpet tile for the healthcare facilities market.
The stock price of Interface has advanced 10.1% in the past four weeks. It has an expected earnings growth rate of 28% for the current year. The Zacks Consensus Estimate for current-year earnings has improved 8.5% over the last 30 days.
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
<a href="https://www.zacks.com/stock/news/2322398/5-stocks-with-recent-price-strength-in-an-uncertain-market?cid=CS-BENZ-FT-analyst_blog|rw-2322398">To read this article on Zacks.com click here.</a>

U.S. stocks were lower, with the Dow Jones index falling over 900 points on Friday.
Shares of MercadoLibre, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MELI#NASDAQ">MELI</a>) rose sharply during Friday's session after the company reported better-than-expected quarterly financial results.
Mercado Libre reported net revenue of $5.07 billion in the second quarter, up 42% year-over-year. The revenue beat a Street consensus estimate of $4.68 billion, according to data from Benzinga Pro.
The company reported a 36% year-over-year increase in total payment volume for the second quarter and a 20% year-over-year rise in gross merchandise volume. Earnings per share were $10.48 in the second quarter, beating a Street consensus estimate of $8.43.
MercadoLibre shares jumped 9.6% to $1,760.79 on Friday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Fitell Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTEL#NASDAQ">FTEL</a>) gained 26% to $24.50.</li>
<li>Tandem Diabetes Care, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNDM#NASDAQ">TNDM</a>) shares surged 23.6% to $43.52 in pre-market trading following better-than-expected second-quarter earnings and strong guidance.</li>
<li>Cerus Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERS#NASDAQ">CERS</a>) gained 23% to $2.5200  after the company reported better-than-expected second-quarter EPS results and raised its FY24 product revenue guidance above estimates..</li>
<li>Integral Ad Science Holding Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAS#NASDAQ">IAS</a>) shares gained 14.9% to $11.38 after the company reported better-than-expected quarterly financial results and issued FY24 revenue guidance above estimates.</li>
<li>Willdan Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WLDN#NASDAQ">WLDN</a>) climbed 10.1% to $36.52 after the company reported better-than-expected second-quarter financial results.</li>
<li>Fresh Del Monte Produce Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDP#NYSE">FDP</a>) gained 8.6% to $26.73 following better-than-expected earnings.</li>
<li>ICF International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICFI#NASDAQ">ICFI</a>) rose 8.3% to $158.06 following upbeat quarterly results.</li>
<li>EZCORP, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZPW#NASDAQ">EZPW</a>) jumped 8.2% to $11.35.</li>
<li>Standard BioTools Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAB#NYSE">LAB</a>) gained 7.7% to $1.530.</li>
<li>Bright Horizons Family Solutions Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BFAM#NYSE">BFAM</a>) gained 7.5% to $127.32 following strong quarterly results.</li>
<li>DoorDash, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DASH#NASDAQ">DASH</a>) rose 6.7% to $115.52 as the company posted upbeat earnings.</li>
<li>GoDaddy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDDY#NYSE">GDDY</a>) jumped 5.8% to $149.66 after the company reported better-than-expected second-quarter sales results..</li>
<li>The Clorox Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>) gained 4.3% to $139.94 after the company reported better-than-expected fourth-quarter adjusted EPS results and issued FY24 adjusted EPS guidance above estimates.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/08/40131885/dow-dips-over-400-points-apple-posts-upbeat-earnings">Dow Dips Over 400 Points; Apple Posts Upbeat Earnings</a></li>
</ul>

EZCORP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZPW#NASDAQ">EZPW</a>) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.21 by 9.52 percent. The company reported quarterly sales of $281.421 million which beat the analyst consensus estimate of $279.546 million by 0.67 percent. This is a 10.01 percent increase over sales of $255.812 million the same period last year.

Earnings Beats

EZCORP Q3 2024 Adj. EPS $0.23 Beats $0.21 Estimate, Sales $281.421M Beat $279.546M Estimate

U.S. stock futures were higher this morning, with the Dow futures gaining around 150 points on Monday.
Shares of Abbott Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>) fell in today&#8217;s pre-market trading after the company was ordered to pay $495 million in damages in its baby formula case.
Abbott shares lost 6.6% to $98.29 in pre-market trading
<ul>
<li>Integra LifeSciences Holdings Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IART#NASDAQ">IART</a>) dipped 20.5% to $25.00 in pre-market trading after the company reported second-quarter results and lowered its FY24 outlook.</li>
<li>NewAmsterdam Pharma Company N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAMS#NASDAQ">NAMS</a>) fell 13.8% to $16.26 in pre-market trading as the company announced topline data from pivotal Phase 3 BROOKLYN clinical trial evaluating Obicetrapib in patients wth Heterozygous Familial Hypercholesterolemia.</li>
<li>EZCORP, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZPW#NASDAQ">EZPW</a>) shares declined 8.8% to $9.41 in pre-market trading.</li>
<li>GeoPark Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPRK#NYSE">GPRK</a>) shares fell 6.5% to $9.52 in pre-market trading. GeoPark, last week, issued second quarter operational update.</li>
<li>Immutep Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMMP#NASDAQ">IMMP</a>) shares dipped 6.5% to $2.03 in pre-market trading. Immutep, last week, announced successful meeting with the FDA on Phase III design in non-small cell lung cancer.</li>
<li>Iovance Biotherapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOVA#NASDAQ">IOVA</a>) shares fell 5.4% to $8.75 in pre-market trading.</li>
<li>ICL Group Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICL#NYSE">ICL</a>) shares fell 4.1% to $4.43 in pre-market trading. ICL will release second quarter results before the opening of the TASE market on Wednesday, Aug. 14.</li>
<li>PDD Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>) slipped 3% to $126.84 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39984123/jim-cramer-is-mystified-by-five-below-predicts-crowdstrike-is-going-to-bottom-here">Jim Cramer Is &#8216;Mystified&#8217; By Five Below, Predicts CrowdStrike &#8216;Is Going To Bottom Here&#8217;</a></li>
</ul>

Pre-Market Outlook

GPRK

IART

IMMP

IOVA

NAMS

Citigourp Global Markets 2% Protected Notes Linked To The Djia

Abbott, Integra LifeSciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Shares of Pitney Bowes Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBI#NYSE">PBI</a>) shares rose sharply in today's pre-market trading following a report indicating that the company has sold a part of its <a href="https://www.benzinga.com/quote/PBI/news">e-commerce business to Stord</a>.
Pitney Bowes shares jumped 12.5% to $7.58 in pre-market trading.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Cognition Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGTX#NASDAQ">CGTX</a>) gained 46% to $3.45 in pre-market trading after the company announced that it will host an investor presentation to discuss results from its phase 2 SHINE study of CT1812 on Monday July 29, 2024.</li>
<li>Longeveron Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGVN#NASDAQ">LGVN</a>) shares climbed 36.3% to $4.69 in pre-market trading after the company disclosed study results from CLEAR MIND Phase 2a clinical trial of Lomecel-B in mild Alzheimer&#8217;s disease.</li>
<li>Planet Image International Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YIBO#NASDAQ">YIBO</a>) rose 35.7% to $3.99 in pre-market trading after jumping around 56% on Friday.</li>
<li>DDC Enterprise Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DDC#NYSE">DDC</a>) shares gained 22.7% to $0.76 in pre-market trading after gaining 6% on Friday.</li>
<li>BurgerFi International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFI#NASDAQ">BFI</a>) gained 22.1% to $0.5133 in pre-market trading. BurgerFi shares jumped 97% on Friday after the company announced it reached a legal settlement agreement with Lion Point Capital. The company agreed to pay $1,350,000 and issue Lion Point 300,000 of preferred stock.</li>
<li>Tivic Health Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIVC#NASDAQ">TIVC</a>) shares gained 19.4% to $0.5395 in pre-market trading after gaining 11% on Friday.</li>
<li>Ambipar Emergency Response (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMBI#NYSE">AMBI</a>) gained 15.5% to $5.34 in pre-market trading after jumping 29% on Friday.</li>
<li>TransCode Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAZ#NASDAQ">RNAZ</a>) shares gained 14.1% to $0.3371 in pre-market trading. TransCode Therapeutics 13G filing showed 3i, LP reported a 9.9% stake in the company, as of July 23.</li>
<li>Anavex Life Sciences Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVXL#NASDAQ">AVXL</a>) gained 11.4% to $7.51 in pre-market trading. Anavex Life Sciences presented comprehensive results from the Phase IIb/III study showing that blarcamesine, once daily orally, significantly slowed clinical decline in people with early Alzheimer&#8217;s disease.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>vTv Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTVT#NASDAQ">VTVT</a>) shares fell 37.4% to $13.28 in pre-market trading after the company announced the FDA has placed a clinical hold on the cadisegliatin clinical program which includes the ongoing CATT1 phase 3 trial in type 1 diabetes.</li>
<li>CERo Therapeutics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERO#NASDAQ">CERO</a>) shares declined 34% to $0.1690 in pre-market trading after gaining 6% on Friday.</li>
<li>LuxUrban Hotels Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUXH#NASDAQ">LUXH</a>) shares fell 22.1% to $0.1488 in pre-market trading after the company priced its $1.74 million public offering of 11,573,333 common shares at 15 cents per share.</li>
<li>Treasure Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGL#NASDAQ">TGL</a>) shares fell 19.6% to $1.48 in pre-market trading.</li>
<li>Globavend Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GVH#NASDAQ">GVH</a>) shares declined 13.1% to $0.63 in pre-market trading after surging 24% on Friday.</li>
<li>Phio Pharmaceuticals Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHIO#NASDAQ">PHIO</a>) fell 12.6% to $3.53 in pre-market trading. Phio Pharmaceuticals recently announced exercise of warrants for $3.1 million gross proceeds.</li>
<li>INVO Bioscience, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INVO#NASDAQ">INVO</a>) shares fell 11.6% to $0.7250 in pre-market trading after jumping 11% on Friday.</li>
<li>NuZee Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUZE#NASDAQ">NUZE</a>) fell 9.7% to $3.40 in pre-market trading after surging around 25% on Friday.</li>
<li>EZCORP, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZPW#NASDAQ">EZPW</a>) shares dipped 8.8% to $9.41 in pre-market trading.</li>
<li>Abbott Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>) shares fell 6.6% to $98.29 in pre-market trading. A jury ordered Abbott to pay $495 million in compensation and damages in a baby-formula verdict, the Wall Street Journal reported.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39984123/jim-cramer-is-mystified-by-five-below-predicts-crowdstrike-is-going-to-bottom-here">Jim Cramer Is &#8216;Mystified&#8217; By Five Below, Predicts CrowdStrike &#8216;Is Going To Bottom Here</a><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39984123/jim-cramer-is-mystified-by-five-below-predicts-crowdstrike-is-going-to-bottom-here">&#8216;</a></li>
</ul>

AMBI

AVXL

CERO

CGTX

INVO

LGVN

LUXH

NUZE

PHIO

RNAZ

TIVC

VTVT

YIBO

Why Pitney Bowes Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket

Canaccord Genuity analyst Brian McNamara maintains EZCORP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZPW#NASDAQ">EZPW</a>) with a Buy and lowers the price target from $18 to $17.

Price Target

Canaccord Genuity Maintains Buy on EZCORP, Lowers Price Target to $17

EZCORP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZPW#NASDAQ">EZPW</a>) reported quarterly earnings of $0.28 per share which beat the analyst consensus estimate of $0.26 by 7.69 percent. This is a 21.74 percent increase over earnings of $0.23 per share from the same period last year. The company reported quarterly sales of $285.639 million which beat the analyst consensus estimate of $282.195 million by 1.22 percent. This is a 10.53 percent increase over sales of $258.423 million the same period last year.

EZCORP Q2 2024 Adj EPS $0.28 Beats $0.26 Estimate, Sales $285.639M Beat $282.195M Estimate

Canaccord Genuity analyst Brian McNamara maintains EZCORP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZPW#NASDAQ">EZPW</a>) with a Buy and raises the price target from $17 to $18.

Canaccord Genuity Maintains Buy on EZCORP, Raises Price Target to $18

WIIM

EZCORP shares are trading higher after the company reported better-than-expected Q1 financial results.

U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Thursday.
Shares of Eaton Corporation plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/etn#NYSE">ETN</a>) rose sharply during Thursday&rsquo;s session after the company reported better-than-expected fourth-quarter <a href="https://www.benzinga.com/quote/ETN/earnings">financial results and issued FY24 guidance</a>.
Eaton posted adjusted earnings of $2.55 per share, beating market estimates of $2.47 per share. The company&rsquo;s quarterly sales came in at $5.97 billion versus expectations of $5.91 billion, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Eaton shares gained 6.2% to $261.48 on Thursday.
Here are some other big stocks recording gains in today&rsquo;s session.
<ul>
<li>Cimpress plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmpr#NASDAQ">CMPR</a>) shares surged 28.8% to $96.90 after the company reported better-than-expected second-quarter financial results and said the board authorized the repurchase of up to $150 million of company shares.</li>
<li>Nextracker Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxt#NASDAQ">NXT</a>) rose gained 18.8% to $53.79 after the company reported better-than-expected third-quarter financial results.</li>
<li>SunPower Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spwr#NASDAQ">SPWR</a>) gained 18.1% to $3.5791.</li>
<li>Corteva, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ctva#NYSE">CTVA</a>) rose 16.2% to $52.84 after the company reported better-than-expected quarterly financial results, issued 2024 guidance and announced a $1 billion repurchase plan.</li>
<li>Nextracker Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nxt#NYSE">NXT</a>) surged 16.1% to $52.56 after the company reported better-than-expected quarterly financial results.</li>
<li>Olema Pharmaceuticals, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/olma#NASDAQ">OLMA</a>) gained 13.3% to $14.78. Olema Pharmaceuticals filed prospectus related to resale of up to 13.2 million shares of common stock held by selling stockholders.</li>
<li>Plug Power Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plug#NASDAQ">PLUG</a>) rose 12.2% to $4.9900. Plug Power said it completed first customer fill of liquid green hydrogen at its Georgia plant.</li>
<li>Credit Acceptance Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cacc#NASDAQ">CACC</a>) gained 11.9% to $605.43 following upbeat earnings.</li>
<li>Digi International Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dgii#NASDAQ">DGII</a>) rose 11.7% to $27.17 following strong results.</li>
<li>EZCORP, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ezpw#NASDAQ">EZPW</a>) rose 11.6% to $9.61 after the company reported better-than-expected quarterly financial results.</li>
<li>Allegro MicroSystems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/algm#NASDAQ">ALGM</a>) surged 10.9% to $28.77 following upbeat earnings.</li>
<li>Ferrari N.V. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/race#NYSE">RACE</a>) rose 10.4% to $382.17 after the company reported fourth-quarter financial results and issued 2024 guidance.</li>
<li>Lancaster Colony Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lanc#NASDAQ">LANC</a>) surged 10% to $202.15 following strong earnings.</li>
<li>Absci Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/absi#NASDAQ">ABSI</a>) gained 9.8% to $4.35.</li>
<li>Etsy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/etsy#NASDAQ">ETSY</a>) climbed 9.6% to $72.95 after the company announced the appointment of Elliott Investment Management&rsquo;s Marc Steinberg to its board.</li>
<li>Boot Barn Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/boot#NYSE">BOOT</a>) rose 8.4% to $77.79 following upbeat earnings.</li>
<li>KB Financial Group Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kb#NYSE">KB</a>) gained 8.3% to $45.77.</li>
<li>Arvinas, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arvn#NASDAQ">ARVN</a>) rose 8.3% to $44.94. Goldman Sachs analyst Paul Choi initiated coverage on Arvinas with a Buy rating and announced a price target of $70.</li>
<li>Sally Beauty Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sbh#NYSE">SBH</a>) climbed 7.4% to $13.24 following upbeat earnings.</li>
<li>Norfolk Southern Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nsc#NYSE">NSC</a>) gained 7.4% to $251.33. The Wall Street Journal reported that Ancora-led investor group has a $1 billion stake in Norfolk Southern, citing sources.</li>
<li>EverQuote, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ever#NASDAQ">EVER</a>) climbed 7.2% to $13.53.</li>
<li>Tenet Healthcare Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/thc#NYSE">THC</a>) rose 6.2% to $87.76.</li>
<li>Deutsche Bank Aktiengesellschaft (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/db#NYSE">DB</a>) shares rose 6.2% to $13.65 after the company posted fourth-quarter results and announced plans to cut 3,500 jobs. Deutsche Bank plans to increase both share repurchases and dividends by at least 50% year-over-year in 2024.</li>
<li>Ball Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ball#NYSE">BALL</a>) jumped 6% to $58.78 following strong earnings.</li>
<li>Li Auto Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/li#NASDAQ">LI</a>) climbed 5.8% to $29.30. Li Auto delivered 31,165 vehicles in January 2024, up 105.8% year over year.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/24/02/36886194/at-t-to-rally-around-19-here-are-10-top-analyst-forecasts-for-thursday"> AT&amp;T To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday</a>

Penny Stocks

ABSI

ALGM

ARVN

BALL

BOOT

CACC

CMPR

CTVA

DGII

ETSY

EVER

LANC

OLMA

PLUG

RACE

SPWR

Eaton Posts Strong Results, Joins Ferrari, Boot Barn And Other Big Stocks Moving Higher On Thursday

EZCORP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZPW#NASDAQ">EZPW</a>) reported its Q1 earnings results on Wednesday, January 31, 2024 at 04:30 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
EZCORP beat estimated earnings by 28.57%, reporting an EPS of $0.36 versus an estimate of $0.28.
Revenue was up $35.66 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company beat on EPS by $0.06 which was followed by a 3.37% drop in the share price the next day.
Here's a look at EZCORP's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.17</td>
<td>0.15</td>
<td>0.15</td>
<td>0.22</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.23</td>
<td>0.20</td>
<td>0.23</td>
<td>0.28</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>263.02M</td>
<td>244.66M</td>
<td>246.88M</td>
<td>244.86M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>270.48M</td>
<td>255.81M</td>
<td>258.42M</td>
<td>264.33M</td>
</tr>
</tbody>
</table>

To track all earnings releases for EZCORP <a href="https://www.benzinga.com/quote/EZPW/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Recap: EZCORP Q1 Earnings

EZCORP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZPW#NASDAQ">EZPW</a>) reported quarterly earnings of $0.36 per share which beat the analyst consensus estimate of $0.28 by 28.57 percent. This is a 28.57 percent increase over earnings of $0.28 per share from the same period last year. The company reported quarterly sales of $299.99 million which beat the analyst consensus estimate of $296.13 million by 1.30 percent. This is a 13.49 percent increase over sales of $264.33 million the same period last year.

EZCORP Q1 Adj EPS $0.36 Beats $0.28 Estimate, Sales $299.99M Beat $296.13M Estimate

<h3>Companies Reporting Before The Bell</h3>
&bull; Novartis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVS#NYSE">NVS</a>) is likely to report quarterly earnings at $1.68 per share on revenue of $11.56 billion.
&bull; Novo Nordisk (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) is likely to report quarterly earnings at $0.65 per share on revenue of $8.82 billion.
&bull; Regis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGS#NASDAQ">RGS</a>) is likely to report quarterly loss at $1.19 per share on revenue of $52.94 million.
&bull; Boeing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) is projected to report quarterly loss at $0.74 per share on revenue of $21.12 billion.
&bull; Hess (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HES#NYSE">HES</a>) is likely to report quarterly earnings at $1.47 per share on revenue of $2.60 billion.
&bull; Lennox Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LII#NYSE">LII</a>) is expected to report quarterly earnings at $3.48 per share on revenue of $1.14 billion.
&bull; Nasdaq (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDAQ#NASDAQ">NDAQ</a>) is estimated to report quarterly earnings at $0.70 per share on revenue of $1.03 billion.
&bull; Evercore (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVR#NYSE">EVR</a>) is expected to report quarterly earnings at $1.66 per share on revenue of $715.79 million.
&bull; Aptiv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APTV#NYSE">APTV</a>) is estimated to report quarterly earnings at $1.32 per share on revenue of $5.04 billion.
&bull; Brinker International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EAT#NYSE">EAT</a>) is expected to report quarterly earnings at $0.96 per share on revenue of $1.08 billion.
&bull; Cencora (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COR#NYSE">COR</a>) is likely to report earnings for its first quarter.
&bull; CGI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIB#NYSE">GIB</a>) is likely to report quarterly earnings at $1.36 per share on revenue of $2.68 billion.
&bull; Mastercard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>) is likely to report quarterly earnings at $3.08 per share on revenue of $6.48 billion.
&bull; Avnet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVT#NASDAQ">AVT</a>) is likely to report quarterly earnings at $1.40 per share on revenue of $6.17 billion.
&bull; Hess Midstream (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HESM#NYSE">HESM</a>) is projected to report quarterly earnings at $0.63 per share on revenue of $357.92 million.
&bull; M/I Homes (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MHO#NYSE">MHO</a>) is estimated to report quarterly earnings at $4.94 per share on revenue of $1.19 billion.
&bull; Fortive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTV#NYSE">FTV</a>) is estimated to report quarterly earnings at $0.94 per share on revenue of $1.56 billion.
&bull; Radcom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDCM#NASDAQ">RDCM</a>) is projected to report quarterly earnings at $0.15 per share on revenue of $13.55 million.
&bull; Silicon Laboratories (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLAB#NASDAQ">SLAB</a>) is likely to report quarterly loss at $1.43 per share on revenue of $85.16 million.
&bull; Old Dominion Freight Line (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODFL#NASDAQ">ODFL</a>) is likely to report quarterly earnings at $2.85 per share on revenue of $1.50 billion.
&bull; Rockwell Automation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROK#NYSE">ROK</a>) is projected to report quarterly earnings at $2.63 per share on revenue of $2.10 billion.
&bull; Automatic Data Processing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADP#NASDAQ">ADP</a>) is projected to report quarterly earnings at $2.10 per share on revenue of $4.66 billion.
&bull; Silgan Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLGN#NYSE">SLGN</a>) is projected to report quarterly earnings at $0.58 per share on revenue of $1.39 billion.
&bull; Columbus McKinnon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCO#NASDAQ">CMCO</a>) is projected to report quarterly earnings at $0.68 per share on revenue of $250.34 million.
&bull; Group 1 Automotive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPI#NYSE">GPI</a>) is estimated to report quarterly earnings at $10.48 per share on revenue of $4.41 billion.
&bull; Thermo Fisher Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMO#NYSE">TMO</a>) is expected to report quarterly earnings at $5.64 per share on revenue of $10.73 billion.
&bull; GSK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GSK#NYSE">GSK</a>) is likely to report quarterly earnings at $0.75 per share on revenue of $9.61 billion.
&bull; Nomura Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NMR#NYSE">NMR</a>) is projected to report earnings for its third quarter.
&bull; Extreme Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXTR#NASDAQ">EXTR</a>) is expected to report quarterly earnings at $0.25 per share on revenue of $295.61 million.
&bull; New York Community (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYCB#NYSE">NYCB</a>) is expected to report quarterly earnings at $0.28 per share on revenue of $803.17 million.
&bull; Phillips 66 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSX#NYSE">PSX</a>) is likely to report quarterly earnings at $2.34 per share on revenue of $36.29 billion.
&bull; Teva Pharmaceutical Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEVA#NYSE">TEVA</a>) is projected to report quarterly earnings at $0.76 per share on revenue of $4.01 billion.
&bull; Roper Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROP#NASDAQ">ROP</a>) is expected to report quarterly earnings at $4.34 per share on revenue of $1.58 billion.
&bull; Avery Dennison (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVY#NYSE">AVY</a>) is projected to report quarterly earnings at $2.16 per share on revenue of $2.09 billion.
&bull; MarketAxess Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKTX#NASDAQ">MKTX</a>) is projected to report quarterly earnings at $1.73 per share on revenue of $195.93 million.
&bull; Otis Worldwide (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OTIS#NYSE">OTIS</a>) is estimated to report quarterly earnings at $0.86 per share on revenue of $3.57 billion.
&bull; Navient (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAVI#NASDAQ">NAVI</a>) is likely to report quarterly earnings at $0.75 per share on revenue of $201.17 million.
&bull; Central Pacific Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPF#NYSE">CPF</a>) is estimated to report quarterly earnings at $0.48 per share on revenue of $50.78 million.
&bull; Boston Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) is estimated to report quarterly earnings at $0.51 per share on revenue of $3.59 billion.
&bull; Banco Santander (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAN#NYSE">SAN</a>) is estimated to report earnings for its fourth quarter.
&bull; United Microelectronics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UMC#NYSE">UMC</a>) is likely to report quarterly earnings at $0.15 per share on revenue of $1.70 billion.
<h3>Companies Reporting After The Bell</h3>
&bull; Keysight Techs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEYS#NYSE">KEYS</a>) is projected to report earnings for its first quarter.
&bull; EZCORP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZPW#NASDAQ">EZPW</a>) is estimated to report quarterly earnings at $0.29 per share on revenue of $296.28 million.
&bull; Markel Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKL#NYSE">MKL</a>) is estimated to report quarterly earnings at $21.36 per share on revenue of $3.76 billion.
&bull; John B Sanfilippo &amp; Son (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBSS#NASDAQ">JBSS</a>) is estimated to report earnings for its second quarter.
&bull; Unifi (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UFI#NYSE">UFI</a>) is likely to report quarterly loss at $0.85 per share on revenue of $135.57 million.
&bull; Credit Acceptance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CACC#NASDAQ">CACC</a>) is expected to report quarterly earnings at $5.99 per share on revenue of $460.96 million.
&bull; SEI Inv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEIC#NASDAQ">SEIC</a>) is projected to report quarterly earnings at $0.92 per share on revenue of $479.93 million.
&bull; Good Times Restaurants (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTIM#NASDAQ">GTIM</a>) is estimated to report earnings for its first quarter.
&bull; Selective Insurance Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIGI#NASDAQ">SIGI</a>) is estimated to report quarterly earnings at $1.94 per share on revenue of $958.13 million.
&bull; Hanover Insurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THG#NYSE">THG</a>) is expected to report quarterly earnings at $2.73 per share on revenue of $1.41 billion.
&bull; Brandywine Realty Tr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BDN#NYSE">BDN</a>) is estimated to report quarterly loss at $0.07 per share on revenue of $135.47 million.
&bull; DLH Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLHC#NASDAQ">DLHC</a>) is likely to report quarterly earnings at $0.12 per share on revenue of $101.00 million.
&bull; AvalonBay Communities (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVB#NYSE">AVB</a>) is estimated to report quarterly earnings at $1.34 per share on revenue of $701.24 million.
&bull; Boot Barn Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOOT#NYSE">BOOT</a>) is likely to report quarterly earnings at $1.77 per share on revenue of $521.22 million.
&bull; C.H. Robinson Worldwide (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHRW#NASDAQ">CHRW</a>) is projected to report quarterly earnings at $0.81 per share on revenue of $4.34 billion.
&bull; 8x8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) is estimated to report quarterly earnings at $0.10 per share on revenue of $183.49 million.
&bull; Axis Capital Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXS#NYSE">AXS</a>) is estimated to report quarterly earnings at $1.08 per share on revenue of $1.23 billion.
&bull; Hawkins (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HWKN#NASDAQ">HWKN</a>) is projected to report quarterly earnings at $0.61 per share on revenue of $221.24 million.
&bull; Accuray (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARAY#NASDAQ">ARAY</a>) is projected to report quarterly loss at $0.05 per share on revenue of $106.67 million.
&bull; Wolfspeed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>) is likely to report quarterly loss at $0.66 per share on revenue of $206.25 million.
&bull; Kulicke &amp; Soffa Indus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLIC#NASDAQ">KLIC</a>) is projected to report quarterly earnings at $0.26 per share on revenue of $172.01 million.
&bull; MaxLinear (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MXL#NASDAQ">MXL</a>) is expected to report quarterly earnings at $0.01 per share on revenue of $125.11 million.
&bull; Flex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLEX#NASDAQ">FLEX</a>) is likely to report quarterly earnings at $0.61 per share on revenue of $6.73 billion.
&bull; Aflac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AFL#NYSE">AFL</a>) is likely to report quarterly earnings at $1.45 per share on revenue of $4.40 billion.
&bull; Century Communities (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCS#NYSE">CCS</a>) is expected to report quarterly earnings at $2.28 per share on revenue of $896.79 million.
&bull; Digi Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGII#NASDAQ">DGII</a>) is expected to report quarterly earnings at $0.44 per share on revenue of $105.61 million.
&bull; Qualcomm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) is estimated to report quarterly earnings at $2.37 per share on revenue of $9.51 billion.
&bull; BrightView Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BV#NYSE">BV</a>) is likely to report quarterly earnings at $0.04 per share on revenue of $645.09 million.
&bull; Qorvo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QRVO#NASDAQ">QRVO</a>) is projected to report quarterly earnings at $1.66 per share on revenue of $1.00 billion.
&bull; UGI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UGI#NYSE">UGI</a>) is estimated to report quarterly earnings at $1.05 per share on revenue of $2.67 billion.
&bull; MagnaChip Semiconductor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MX#NYSE">MX</a>) is likely to report quarterly loss at $0.26 per share on revenue of $52.47 million.
&bull; Core Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLB#NYSE">CLB</a>) is likely to report quarterly earnings at $0.19 per share on revenue of $127.92 million.
&bull; Meritage Homes (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTH#NYSE">MTH</a>) is likely to report quarterly earnings at $5.17 per share on revenue of $1.53 billion.
&bull; Corteva (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTVA#NYSE">CTVA</a>) is projected to report quarterly earnings at $0.06 per share on revenue of $3.62 billion.
&bull; MetLife (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MET#NYSE">MET</a>) is expected to report quarterly earnings at $1.90 per share on revenue of $18.46 billion.
&bull; Landstar System (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSTR#NASDAQ">LSTR</a>) is expected to report quarterly earnings at $1.62 per share on revenue of $1.24 billion.
&bull; Rayonier (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RYN#NYSE">RYN</a>) is projected to report quarterly earnings at $0.15 per share on revenue of $229.75 million.
&bull; MGIC Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTG#NYSE">MTG</a>) is expected to report quarterly earnings at $0.57 per share on revenue of $292.72 million.
&bull; NEXTracker (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXT#NASDAQ">NXT</a>) is estimated to report quarterly earnings at $0.48 per share on revenue of $619.23 million.
&bull; Conmed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNMD#NYSE">CNMD</a>) is estimated to report quarterly earnings at $1.11 per share on revenue of $332.20 million.
&bull; Landmark Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LARK#NASDAQ">LARK</a>) is likely to report earnings for its fourth quarter.
&bull; PTC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTC#NASDAQ">PTC</a>) is expected to report quarterly earnings at $0.96 per share on revenue of $538.63 million.
&bull; Align Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGN#NASDAQ">ALGN</a>) is expected to report quarterly earnings at $2.16 per share on revenue of $931.35 million.
&bull; Vista Outdoor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSTO#NYSE">VSTO</a>) is estimated to report quarterly earnings at $0.81 per share on revenue of $687.67 million.
&bull; Tetra Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTEK#NASDAQ">TTEK</a>) is likely to report quarterly earnings at $1.34 per share on revenue of $990.66 million.
&bull; Benchmark Electronics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHE#NYSE">BHE</a>) is projected to report quarterly earnings at $0.56 per share on revenue of $707.50 million.
&bull; NewMarket (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEU#NYSE">NEU</a>) is likely to report earnings for its fourth quarter.
&bull; Cimpress (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPR#NASDAQ">CMPR</a>) is expected to report quarterly earnings at $1.24 per share on revenue of $892.10 million.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

ALGN

APTV

ARAY

CHRW

CMCO

CNMD

DLHC

EGHT

EXTR

FLEX

GTIM

HESM

HWKN

JBSS

KEYS

KLIC

LARK

LSTR

MKTX

NAVI

NDAQ

NYCB

ODFL

OTIS

QCOM

QRVO

RDCM

SEIC

SIGI

SLAB

SLGN

TEVA

TTEK

VSTO

WOLF

Earnings Scheduled For January 31, 2024

EZCORP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZPW#NASDAQ">EZPW</a>) is set to give its latest quarterly earnings report on Wednesday, 2024-01-31. Here's what investors need to know before the announcement.
Analysts estimate that EZCORP will report an earnings per share (EPS) of $0.29. 
EZCORP bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Past Earnings Performance</h3>
Last quarter the company beat EPS by $0.06, which was followed by a 3.37% drop in the share price the next day.
Here's a look at EZCORP's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.17</td>
<td>0.15</td>
<td>0.15</td>
<td>0.22</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.23</td>
<td>0.20</td>
<td>0.23</td>
<td>0.28</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-3.37%</td>
<td>6.56%</td>
<td>-1.6%</td>
<td>0.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1706644893_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of EZCORP were trading at $8.78 as of January 29. Over the last 52-week period, shares are down 4.37%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/EZPW/earnings">To track all earnings releases for EZCORP visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Preview Of EZCORP's Earnings

EZCORP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZPW#NASDAQ">EZPW</a>) reported its Q4 earnings results on Wednesday, November 15, 2023 at 04:15 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
EZCORP beat estimated earnings by 35.29%, reporting an EPS of $0.23 versus an estimate of $0.17.
Revenue was up $37.07 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company beat on EPS by $0.05 which was followed by a 6.56% increase in the share price the next day.
Here's a look at EZCORP's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.15</td>
<td>0.15</td>
<td>0.22</td>
<td>0.12</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.20</td>
<td>0.23</td>
<td>0.28</td>
<td>0.15</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>244.66M</td>
<td>246.88M</td>
<td>244.86M</td>
<td>209.08M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>255.81M</td>
<td>258.42M</td>
<td>264.33M</td>
<td>233.41M</td>
</tr>
</tbody>
</table>

To track all earnings releases for EZCORP <a href="https://www.benzinga.com/quote/EZPW/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Recap: EZCORP Q4 Earnings

EZCORP Q4 Adj. Total Revenue $261.4M vs $265.786M Est., Adj. EPS $0.23 vs $0.19 Est.

EZCORP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZPW#NASDAQ">EZPW</a>) is set to give its latest quarterly earnings report on Wednesday, 2023-11-15. Here's what investors need to know before the announcement.
Analysts estimate that EZCORP will report an earnings per share (EPS) of $0.17. 
EZCORP bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Historical Earnings Performance</h3>
Last quarter the company beat EPS by $0.05, which was followed by a 6.56% increase in the share price the next day.
Here's a look at EZCORP's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.15</td>
<td>0.15</td>
<td>0.22</td>
<td>0.12</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.20</td>
<td>0.23</td>
<td>0.28</td>
<td>0.15</td>
</tr>
<tr>
<td>Price Change %</td>
<td>6.56%</td>
<td>-1.6%</td>
<td>0.0%</td>
<td>-3.78%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2023/1699977674_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of EZCORP were trading at $8.25 as of November 13. Over the last 52-week period, shares are down 13.6%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/EZPW/earnings">To track all earnings releases for EZCORP visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Preview For EZCORP

An announcement from EZCORP (EZPW) is now available. EZCORP's latest earnings call presentation will be available on their website in the Investor ...

EZCORP Earnings Call Details Available Online

EZCORP Non-GAAP EPS of $0.23 beats by $0.02, revenue of $281.4M beats by $1.85M

EZCORP, Inc. 2024 Q3 - Results - Earnings Call Presentation

EZCORP, Inc. (EZPW) Q3 2024 Earnings Call Transcript

Rare Stock Picks In July 2024 - From 29 Discerning Analysts

Heritage Insurance, EZCORP, and Erie Indemnity have all enjoyed positive price action over the last month. But what's driving the outperformance? Let's take a closer look.

3 Buy Rated Finance Stocks Flashing Relative Strength: HRTG, ERIE, EZPW

EZCORP: Continues To Outperform In Tough Environment

EZCORP announces agreement to acquire 53 pawn stores in Mexico

EZCORP ( ($EZPW) ) has shared an announcement. EZCORP, Inc., a prominent pawn loan provider, is set to broaden its presence in the Mexican market w...

EZCORP Expands in Mexico with Auto Pawn Acquisition

Brian McNamara, an analyst from Canaccord Genuity, maintained the Buy rating on EZCORP (EZPW – Research Report). The associated price target remain...

Buy Rating Justified by EZCORP's Strategic Expansion and Growth Potential

AANNF

AMNF

BLZE

BYRN

CLOZ

CPRI

DUOL

ERIE

FINV

FSLR

FTCO

HRTG

LUNR

MNST

MUSA

NXST

PSFE

RMTI

SOFI

UPWK

Opinion

Press Releases

Thinking about buying stock in MicroCloud Hologram, CleanSpark, Cardiol Therapeutics, Atlasclear Holdings, or EZCORP?

EZCORP Announces Annual Meeting of Shareholders via Conference Call on Thursday, March 21, 2024

EZCORP to Release Second Quarter Fiscal 2024 Results After Market Close on Wednesday, May 1, 2024

EZCORP Reports Second Quarter Fiscal 2024 Results

EZCORP to Participate in June Conferences

EZCORP to Release Third Quarter Fiscal 2024 Results After Market Close on Wednesday, July 31, 2024

EZCORP Reports Third Quarter Fiscal 2024 Results

EZPAWN Unveils New Services and Sneaker Pawn for Back-to-School and Holiday Shoppers

EZCORP to Participate in the Canaccord Genuity 44th Annual Growth Conference

EZCORP Announces Agreement to Acquire 53 Pawn Stores in Mexico

ATCH

CLSK

CRDL

HOLO

Atlanticus Holdings Corporation - Common Stock

Atlanticus Holdings

Consumer Portfolio Services, Inc. - Common Stock

Consumer Pf Servs

Encore Capital Gr

Enova International

FinVolution Group American Depositary Shares

FinVolution Gr

Green Dot Corporation Class A Common Stock, $0.001 par value

Green Dot

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

EZCORP

EZCORP (EZPW) Forecast

EZCORP (NASDAQ:EZPW) Stock, Quote.Headers.trade-ideas